期刊文献+

PAI-1、VN与肝脏疾病 被引量:6

下载PDF
导出
出处 《临床肝胆病杂志》 CAS 北大核心 1999年第4期210-212,共3页 Journal of Clinical Hepatology
  • 相关文献

同被引文献40

  • 1潘家绮,张之南.纤溶系的活化,抑制物及其临床意义[J].中华内科杂志,1993,32(1):14-16. 被引量:4
  • 2王要军,孙自勤.肝窦内皮细胞与肝纤维化[J].临床肝胆病杂志,1996,12(3):115-117. 被引量:17
  • 3杨树平,吕秀珍,陈图兴,赵志泉,孙宏训.肝硬化患者血浆tPA、PAI活性测定的临床意义[J].南京医科大学学报(自然科学版),1996,16(6):554-555. 被引量:6
  • 4Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:271
  • 5王宝恩 潘国宗 等.肝硬化.现代胃肠病学下册[M].北京:科学技术出版社,1998.1500-1523.
  • 6[3]Eyken VP, Sciot R, Desmet VJ. Expression of the novel extracellular matrix component tenascin in normal and diseased human liver: An immunohestochemical study[J]. J Hepatol, 1990,11 (1): 43
  • 7[4]Yanauchi M, Nakajima H, Ohata M, et al. Detection of fibron ectin receptor in sera:Its clinical significance as a parametar of hepatic fibrosis [J]. Hepatology, 1991,14 (2): 244
  • 8[5]Eyken VP, Geerts A,DeBleser P, et al. Localization and cellular source of the extracellular matrix protein tenascin in normal and fibrotic rat liver [J]. Hepatology, 1992,15(5) :909
  • 9[6]Znuzuka S, Ueno T, Torimura T, et al. The significance of colocalization of plasminogen activator inhibitor- I and vitronectin in hepatic fibrosis[J].Gastroenterol J, 1997,32 (4): 1052.
  • 10[8]Okuno M, Moriwaki H,Imai S,et al. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF - β in liver stellate cells [J].Hepatology, 1997,26(4) :913

引证文献6

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部